Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer TherapeuticGregor Rossmueller, Alexander Schinagl|Molecular Cancer Therapeutics|2023Cited by 17